WSJ Your Money Briefing What’s News in Markets: Novo Tumbles, Meta Soars, Apple Sells
7 snips
Aug 2, 2025 Is Novo Nordisk's grip on the weight-loss market slipping as its stock tumbles? Meanwhile, a surge in Meta’s shares raises eyebrows. Discover what's behind Apple’s impressive iPhone sales as shoppers flock to stores. The discussion dives into the recent market fluctuations driven by tariffs, leadership changes, and corporate earnings, offering insights into the ever-evolving landscape of stock performance.
AI Snips
Chapters
Transcript
Episode notes
Novo Nordisk Market Challenges
- Novo Nordisk faces challenges in maintaining its dominance in the weight-loss drug market.
- Competition from Eli Lilly and knockoff drug manufacturers pressures its growth.
Meta's Revenue and AI Growth
- Meta's strong revenue growth is driven by its advertising business supporting AI initiatives.
- The company's quarterly sales and net income beat expectations, lifting its shares significantly.
Microsoft Hits $4 Trillion Valuation
- Microsoft's cloud computing and AI demand boosted its financial results.
- It became the second company to reach a $4 trillion market valuation.